Upgrade to SI Premium - Free Trial

Anthem (ANTM) Tops Q3 EPS by 11c, Revenues Beat; Offers FY18 EPS Outlook Above Consensus, Affirms FY18 Revenue Ooutlook

October 31, 2018 6:05 AM

Anthem (NYSE: ANTM) reported Q3 EPS of $3.81, $0.11 better than the analyst estimate of $3.70. Revenue for the quarter came in at $22.98 billion versus the consensus estimate of $22.93 billion.

"Our third quarter 2018 results reflect solid operating performance and ongoing positive momentum across our businesses, and I am confident that we are entering 2019 in a position of strength. We have made significant progress towards improving execution and are focused on advancing our consumer, clinical, and digital capabilities. We remain committed to accelerating growth and will continue to invest in innovative, effective, and scalable healthcare solutions designed to improve the quality and total cost of care for our members," said Gail K. Boudreaux, President and CEO. "I am pleased with our results through the first nine months of 2018. As result, we have increased our 2018 outlook to reflect our expectation for continued growth."


Anthem sees Q4 2018 EPS of $15.60, versus the consensus of $15.50. Anthem sees Q4 2018 revenue of $91-92 billion, versus the consensus of $91.43 billion.

For earnings history and earnings-related data on Anthem (ANTM) click here.


Earnings Guidance Hot Guidance Management Comments

Next Articles